We use cookies to improve your experience on our site. By using our site you consent to the use of cookies. Learn More
The Trinity Challenge on Antimicrobial Resistance has awarded four innovative solutions with funding Learn about our winners
22 February 2024
[Originally published by the Union for International Cancer Control]
“I think antibiotics and other antimicrobials, antifungals are terrifically important to cancer patients. After all, we know that as many as 1 in 5 cancer patients undergoing treatment are hospitalised with an infection. So antibiotics and other antimicrobials are their main line of defence. Pneumonia and sepsis - that's bacterial infection of the blood - are the most frequent cause of admission to intensive care for cancer patients, and it's estimated that at least 8.5% of cancer deaths are due to severe sepsis. So, you know, if we don't protect our antibiotics and antifungals and everything, we're not protecting our patients.
“And we have surveys showing that 95% of oncologists worry about the impact of superbugs on the future of cancer treatments. Nearly half of those surveyed said they think chemotherapy will at some point become unviable. And it's not that far away if we don't sort this out. So I don't want people to take antibiotics if they don't need them so they are available for those like cancer patients when they do need them.” – Prof. Dame Sally Davies
Prof. Dame Sally Davies (Founder and Chair, the Trinity Challenge) joined Dr. Cary Adams (CEO, Union for International Cancer Control) to discuss the relationship between antimicrobial resistance and cancer care in an episode of the Let’s Talk Cancer podcast from the Union for Internation Cancer Control.
You can listen to the conversation here.
“While innovative and effective ideas to help solve major global health problems are hard to come by, finding and attaining funding to put them into action can be even more difficult. The research grant review process takes time and can be bogged down in red tape...
Sky News Daily Podcast: Women in public health: Dermot Murnaghan is joined by the former Chief Medical Officer for England, Dame Sally Davies, and infectious disease expert, Professor Wendy Barclay from Imperial College London.